Unichem in merger deal
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Unichem in merger deal
UniChem, the pharmaceuticals distributor chaired by former Chancellor of the Exchequer, Kenneth Clarke, is to merge with Alliance Sante in a deal worth pounds 278m. The new company, Alliance UniChem, will be one of the leading healthcare companies in Europe. Alliance Sante has significant market positions in both France and Italy. The deal ends UniChem's search for a partner which began when it lost the battle for control for Lloyds Chemists to Gehe of Germany earlier this year. The enlarged group will have combined sales of almost pounds 5bn and profits before re-structuring costs of pounds 102m.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments